TW
About
Thomas W. Dubensky is the current President and CEO of ImmuneSensor Therapeutics. He previously worked at Theriva Biologics, Inc. as a Scientific Advisory Board Member. Thomas W. Dubensky attended the University of California, San Diego.
Position in the VCSift Database
- • 287 investors hold the President & CEO role in VCSift. Thomas W. Dubensky is one of them.
- • 195 investors are based in Berkeley, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Berkeley, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Thomas
Search Investors